CARNBO CLINICAL RESEARCH LIMITED

💤Zombieactive
SC233121 · ltd · incorporated 2002-06-21
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
Why now
Window opening · high confidence
More negotiable than before — 4 signals weakening over the last 30 days.
  • · Deal-killer verdict: workable → complicated
  • · Opportunity score: 80 → 70
  • · Hygiene score: 90 → 80
  • · PSC count: 1 → 0
Opportunity decay
softening · 6-months
Softening — cumulative signals suggest this becomes more negotiable over the next 3–6 months.
  • · 4 recent signals weakening vs 0 strengthening
What changed my view
Last 30 days

Picture worsened over the last 30 days — 4 negative signals vs 0 positive.

  • Deal-killer verdict: workablecomplicated
  • Opportunity score: 8070
  • Hygiene score: 9080
  • PSC count: 10
Last 90 days

No snapshot from 90 days ago — start tracking from today.

Last 180 days

No snapshot from 180 days ago — start tracking from today.

🔒Estimated value
Upgrade to see
Turnover
year to Jun 2025
Net worth
book net assets
Opportunity
70/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
Pursue
Strong opportunity: active trading company with strong profile and bankable structure.

Opportunity 70/100 (strong), bankability 75/100. Most likely exit: share sale to pe / searcher (58/100).

Data confidence

Overall: low (47/100)

Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
No charge records returned
50
Directors & officers
No officers data
0
Ownership & PSC
No PSC data returned
40
Director network
Network not yet resolved
30
Filing history
No filing history
0
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
70/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
70
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0Jun 2024Jun 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2025-06-302024-06-30
Average employees100100

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →
Corporate timeline (1 events)Click to expand
  1. 2002-06-21
    🏢
    Company incorporated
    As CARNBO CLINICAL RESEARCH LIMITED

Owner dependency

55/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • +No director turnover: Company is 24 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

30/100
Weak signal

Limited succession signal. Not a near-term off-market candidate.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Similar companies

Active · Professional services · KY postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
ANCER RECRUITMENT LTD.
SC205893 · est 2000
520026y8362y
FERSA LTD
SC219538 · est 2001
425y8363y
FLORIDRON LIMITED
SC132297 · est 1991
£747.5k35y8369y
LAURENCE GOULD PARTNERSHIP LIMITED
SC124767 · est 1990 · no financials extracted
36y8372y
PHOTOSYNERGY LIMITED
SC220986 · est 2001 · no financials extracted
25y8358y
PVX LIMITED
SC397170 · est 2011
£144.0k15y8359y
AVENUE SCOTLAND LIMITED
SC147452 · est 1993
£87.8k32y8273y
BALGAY FARMING COMPANY LIMITED
SC093170 · est 1985
20041y8279y
CAIRNSMILL LIMITED
SC144163 · est 1993 · no financials extracted
33y8274y
CDLH LIMITED
SC379307 · est 2010
10016y8267y
DRYBURGH ASSOCIATES LIMITED
SC367732 · est 2009
90016y8268y
FASTTRAC DESIGN LIMITED
SC297992 · est 2006
£4.3k20y8265y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2002-06-21
Jurisdictionscotland
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

Bleachfield Mill
By Auchtermuchty
Fife
KY14 7EF

Filing status

Accounts
Next due: 2027-03-31
Last made up to: 2025-06-30
Confirmation statement
Next due: 2027-07-05
Last: 2026-06-21